Navigation Links
Avanir Pharmaceuticals Announces Diabetes Co-Promotion Agreement with Merck
Date:8/12/2013

ALISO VIEJO, Calif., Aug. 12, 2013 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that it has entered into an exclusive, multi-year agreement with Merck (NYSE: MRK), known as MSD outside the United States and Canada, to co-promote Merck's type 2 diabetes therapies JANUVIA® (sitagliptin) and the sitagliptin family of products in the long-term care institutional setting in the United States.

(Logo: http://photos.prnewswire.com/prnh/20130207/LA55901LOGO)

"As a company dedicated to the advancement of diabetes care, we are excited to partner with Avanir to help improve diabetes management and offer our type 2 diabetes therapies to this patient population," said Peter Alberti, U.S. marketing leader, Diabetes, Merck. "We believe that combining Merck's leadership in diabetes with Avanir's unique capabilities will help this growing population get the diabetes care they need."

Avanir's institutional sales force will promote the sitagliptin family of products to health care practitioners in the long-term care institutional setting beginning in October 2013. Under the terms of this agreement, Avanir will be compensated via a fixed fee plus an incentive-based payment. Merck will continue to remain responsible for the promotion of the sitagliptin family of products in all other settings and will remain responsible for all other aspects of research, manufacturing and marketing.

"We are extremely pleased to enter this agreement with Merck for its key diabetes therapies. This agreement will further advance our vision to become a leading specialt
'/>"/>

SOURCE Avanir Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Avanir Pharmaceuticals Reports Fiscal 2013 Third Quarter Financial and Business Results
2. Avanir Pharmaceuticals to Participate in Two Conferences in August
3. Avanir Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
4. Avanir Pharmaceuticals Announces Accelerated Development Path for AVP-786 Following Successful Pre-IND Meeting with FDA
5. Avanir Pharmaceuticals to Participate in Two Upcoming Investor Conferences
6. Avanir Pharmaceuticals Reports Fiscal 2013 Second Quarter Financial and Business Results
7. Avanir Pharmaceuticals Announces Date of Fiscal 2013 Second Quarter Financial Results and Conference Call
8. Avanir Pharmaceuticals Receives Positive CHMP Opinion for Approval of NUEDEXTA in Europe
9. AVANIR PHARMACEUTICALS ANNOUNCES RESEARCH COLLABORATION WITH DEPARTMENT OF VETERANS AFFAIRS FOR SCREENING PSEUDOBULBAR AFFECT (PBA) SYMPTOMS IN VETERANS WITH TRAUMATIC BRAIN INJURY
10. AVANIR Pharmaceuticals To paticipate in two conferences in March
11. Avanir Pharmaceuticals Reports Fiscal 2013 First Quarter Financial And Business Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... SAN ANTONIO , July 30, 2014 /PRNewswire/ ... technology company focused on innovating lifesaving devices and ... closed $4.5 million in Series A financing, which ... .  Proceeds from the deal will allow Bluegrass ... Inside-Out Access Catheter System, enhance manufacturing capabilities, and ...
(Date:7/30/2014)... , July 30, 2014 ... and CUDA programming expertise to big data, aerospace ... eInfochips, a leading engineering R&D services ... to develop NVIDIA GPU-powered solutions for aerospace ... high-performance computing (HPC), industrial , and ...
(Date:7/29/2014)... , July 29, 2014 /PRNewswire-iReach/ -- The global ... of products, methods, applications, end users, and geographies. ... in the microbial identification market. This favorable growth ... (per test) and the time required for microbial ... technological advancements. Furthermore, genotypic methods have high applications ...
Breaking Medicine Technology:Bluegrass Vascular Technologies Raises $4.5M Series A Financing Led By Targeted Technology Funds 2eInfochips to Develop NVIDIA GPU-powered Solutions for Aerospace and Defense, Medical Imaging, HPC and Visual Computing 2Microbial Identification Market Growing at 5.9% CAGR to 2019: Global Forecast in New Research Report Available at ReportsnReports.com 2Microbial Identification Market Growing at 5.9% CAGR to 2019: Global Forecast in New Research Report Available at ReportsnReports.com 3Microbial Identification Market Growing at 5.9% CAGR to 2019: Global Forecast in New Research Report Available at ReportsnReports.com 4Microbial Identification Market Growing at 5.9% CAGR to 2019: Global Forecast in New Research Report Available at ReportsnReports.com 5Microbial Identification Market Growing at 5.9% CAGR to 2019: Global Forecast in New Research Report Available at ReportsnReports.com 6
(Date:7/30/2014)... July 30, 2014 Calling all runners in ... to announce it will host a monthly Runner’s Injury ... 2231 Old Brick Road the second Monday of each month ... 8, October 13, November 10 and December 8. , ... Participants, who should wear running shoes and attire, will receive ...
(Date:7/30/2014)... CareSource, a nonprofit, Ohio-based health plan, ... CEO, Wright-Patt Credit Union, to the CareSource Ohio Board ... CEO with an extensive background in leading credit unions. ... chief operating officer at Wright-Patt Credit Union (WPCU) in ... Wright-Patt Credit Union that has realized more than seven ...
(Date:7/30/2014)... July 30, 2014 Park Cities ... instituted company-wide staff meetings this month to reinforce best ... Ms. White chose to institute the meetings when ... and amongst staff has become over the past decade. ... her business that allow for quicker processing of customer ...
(Date:7/30/2014)... of traumatic events experienced during deployment, returning National ... drinking problem if faced with civilian life setbacks, ... financial and legal problemsall commonplace in military families. ... University,s Mailman School of Public Health are published ... Medicine . , Alcohol abuse is a major ...
(Date:7/30/2014)... who are born with severe combined immunodeficiency (SCID) can ... cells, according to experts led by Memorial Sloan Kettering,s ... development of transplant protocols. Their review will be published ... England Journal of Medicine . , SCID is a ... to severely malfunction. When this breakdown occurs, babies no ...
Breaking Medicine News(10 mins):Health News:Tidewater Physical Therapy to Host Monthly Runner’s Injury Clinic at 3 Sports Glen Allen Location 2Health News:Tidewater Physical Therapy to Host Monthly Runner’s Injury Clinic at 3 Sports Glen Allen Location 3Health News:Dallas-Based Park Cities Pet Sitter Stresses the Importance of Mindful Communication in This Month’s Staff Meetings, In Addition to Teaching the Signs of Burnout 2Health News:Dallas-Based Park Cities Pet Sitter Stresses the Importance of Mindful Communication in This Month’s Staff Meetings, In Addition to Teaching the Signs of Burnout 3Health News:Dallas-Based Park Cities Pet Sitter Stresses the Importance of Mindful Communication in This Month’s Staff Meetings, In Addition to Teaching the Signs of Burnout 4Health News:Vets' alcohol problems linked to stress on the home front 2Health News:Transplantation shown to be highly effective in treating immune deficiency in children 2
... Wis. , March 15 National Alliance of ... Association,s Institute for Quality and Patient Safety and the New ... they are sponsoring an initiative to expand the number of ... Jersey Wound Care Certification Initiative. This new initiative was borne ...
... FORT WORTH, Texas , March 15 ... a growing  provider of specialty medical products, announced today ... the DFCon 10 Global Diabetic Foot Conference in ... is more than 1000 physicians, clinicians, researchers, scientists, and ...
... naltrexone improves odds of not drinking, researchers say , ... the antidepressant Zoloft (sertraline) and the alcoholism drug naltrexone ... and alcohol dependence will be able to stop drinking, ... patients found that 54 percent of those who received ...
... A potent new inhibitor of HIV, derived from bananas, ... transmission of HIV, according to a University of Michigan Medical ... emerging interest in lectins, naturally occurring chemicals in plants, because ... leads to a variety of infections. In laboratory ...
... HONG KONG , March 15 /PRNewswire-Asia/ -- ... Code: 801), China,s leading,integrated healthcare device and ... shareholders (the "Shareholders") have approved at an,Extraordinary General Meeting ... the board of directors ("the Board") to change the ...
... nurse specialist at the Christiana Care Breast Center at the Helen F. Graham Cancer Center, is the 2010 recipient of the Pearl Moore Making a Difference Award from the ... ... ... ...
Cached Medicine News:Health News:New Jersey Approves Initiative to Expand the Number of Wound Care Certified Professionals 2Health News:New Jersey Approves Initiative to Expand the Number of Wound Care Certified Professionals 3Health News:New Jersey Approves Initiative to Expand the Number of Wound Care Certified Professionals 4Health News:New Jersey Approves Initiative to Expand the Number of Wound Care Certified Professionals 5Health News:Wound Management Technologies, Inc. Announces Conference Plans and Clinical Data Presentation at Leading Diabetic Foot Conference 2Health News:Wound Management Technologies, Inc. Announces Conference Plans and Clinical Data Presentation at Leading Diabetic Foot Conference 3Health News:Wound Management Technologies, Inc. Announces Conference Plans and Clinical Data Presentation at Leading Diabetic Foot Conference 4Health News:Wound Management Technologies, Inc. Announces Conference Plans and Clinical Data Presentation at Leading Diabetic Foot Conference 5Health News:University of Michigan scientists identify chemical in bananas as potent inhibitor of HIV infection 2Health News:Golden Meditech Shareholders Approves of Name Change 2Health News:Golden Meditech Shareholders Approves of Name Change 3Health News:Christiana Care Health System's Darcy Burbage Receives Oncology Nursing Society Award 2Health News:Christiana Care Health System's Darcy Burbage Receives Oncology Nursing Society Award 3
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
Escherichia coli - For the qualitative detection of Escherichia coli 0157 and 0157:H7 in food products Accessories BinaxNOW EH E.coli 0157 & 0157:H7 Control Swab Pack (510-000) ...
... the qualitative differential detection ... antigen and an antigen that ... species of malaria:plasmodium falciparum (P.f), ... (P.o) and Plasmodium malariae (P.m) ...
For the qualitative detection of antibodies to Treponema pallidum in human serum, plasma and whole blood specimens...
Medicine Products: